Hsiao-Fei Lee
Papers
2
Total Citations
9
H-Index
2
About
Hsiao-Fei Lee is a leading researcher in radiation oncology, specializing in stereotactic body radiotherapy (SBRT) and radiosurgery, with a focus on optimizing treatment delivery and assessing long-term patient risks. Her work centers on the CyberKnife M6 system, particularly its lung-optimized treatment (LOT) module, and the balance between plan quality and secondary cancer risk. In a pivotal 2020 study, Lee evaluated lifetime secondary cancer risk (SCR) in lung cancer patients after SBRT using the CyberKnife M6 with LOT, providing critical insights for safer, more effective lung cancer therapy. Her 2019 research further advanced the field by comparing plan quality and SCR in patients with benign intracranial lesions treated with the CyberKnife M6, examining multileaf collimator (MLC)-based versus IRIS-based plans. These contributions, cited over 9 times collectively, underscore her impact on clinical decision-making and patient safety. Lee’s work is notable for integrating dosimetric precision with risk assessment, offering a framework for personalized radiotherapy that minimizes late effects. Her research is essential reading for oncologists and medical physicists seeking to refine SBRT and radiosurgery protocols.
Research Focus
Key Achievements
Top Papers
- 1
- 2